Literature DB >> 17216303

Fluorescent in situ hybridization on tissue microarrays: challenges and solutions.

Lindsay A Brown1, David Huntsman.   

Abstract

Tissue microarray (TMA) technology has provided a high throughput means of evaluating potential biomarkers and therapeutic targets in archival pathological specimens. TMAs facilitate the rapid assessment of molecular alterations in hundreds of different tumours on a single slide. Sections from TMAs can be used for any in situ tissue analysis, including fluorescent in situ hybridization (FISH). FISH is a molecular technique that detects numerical and structural abnormalities in both metaphase chromosomes and interphase nuclei. FISH is commonly used as a prognostic and diagnostic tool for the detection of translocations and for the assessment of gene deletion and amplification in tumours. Performing FISH on TMAs enables researchers to determine the clinical significance of specific genetic alterations in hundreds of highly characterized tumours. The use of FISH on archival paraffin embedded tissues is technically demanding and becomes even more challenging when applied to paraffin embedded TMAs. The problems encountered with FISH on TMAs, including probe preparation, hybridization, and potential applications of FISH, will be addressed in this review.

Entities:  

Mesh:

Year:  2007        PMID: 17216303     DOI: 10.1007/s10735-006-9069-y

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  24 in total

1.  Improved procedure for fluorescence in situ hybridization on tissue microarrays.

Authors:  C L Andersen; G Hostetter; A Grigoryan; G Sauter; A Kallioniemi
Journal:  Cytometry       Date:  2001-10-01

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

Review 3.  Molecular mechanisms underlying human synovial sarcoma development.

Authors:  N R dos Santos; D R de Bruijn; A G van Kessel
Journal:  Genes Chromosomes Cancer       Date:  2001-01       Impact factor: 5.006

4.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

5.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

6.  Tissue microarrays for gene amplification surveys in many different tumor types.

Authors:  P Schraml; J Kononen; L Bubendorf; H Moch; H Bissig; A Nocito; M J Mihatsch; O P Kallioniemi; G Sauter
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

7.  Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.

Authors:  Lindsay A Brown; Julie Irving; Robin Parker; Hanna Kim; Joshua Z Press; Teri A Longacre; Stephen Chia; Anthony Magliocco; Nikita Makretsov; Blake Gilks; Jonathan Pollack; David Huntsman
Journal:  Gynecol Oncol       Date:  2005-10-19       Impact factor: 5.482

8.  TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer.

Authors:  Scott A Tomlins; Rohit Mehra; Daniel R Rhodes; Lisa R Smith; Diane Roulston; Beth E Helgeson; Xuhong Cao; John T Wei; Mark A Rubin; Rajal B Shah; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2006-04-01       Impact factor: 12.701

9.  The clinical application of interphase FISH in prenatal diagnosis.

Authors:  E Pergament; P X Chen; M Thangavelu; M Fiddler
Journal:  Prenat Diagn       Date:  2000-03       Impact factor: 3.050

10.  Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.

Authors:  Camelia I Spiridon; Maria-Ana Ghetie; Jonathan Uhr; Radu Marches; Jia-Ling Li; Guo-Liang Shen; Ellen S Vitetta
Journal:  Clin Cancer Res       Date:  2002-06       Impact factor: 12.531

View more
  12 in total

1.  A new method for real-time evaluation of pepsin digestion of paraffin-embedded tissue sections, prior to fluorescence in situ hybridisation.

Authors:  Xiaojing Teng; Shuhong Zhang; Wei Liu; Kuo Bi; Lei Zhang
Journal:  Virchows Arch       Date:  2017-02-25       Impact factor: 4.064

2.  ESR1 gene amplification in breast cancer: a common phenomenon?

Authors:  Lindsay A Brown; Jeremy Hoog; Suet-Feung Chin; Yu Tao; Abd Alnaser Zayed; Koei Chin; Andrew E Teschendorff; John F Quackenbush; John C Marioni; Samuel Leung; Charles M Perou; Torsten O Neilsen; Matthew Ellis; Joe W Gray; Philip S Bernard; David G Huntsman; Carlos Caldas
Journal:  Nat Genet       Date:  2008-07       Impact factor: 38.330

3.  Ammosamides A and B target myosin.

Authors:  Chambers C Hughes; John B MacMillan; Susana P Gaudêncio; William Fenical; James J La Clair
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

4.  An inexpensive method of small paraffin tissue microarrays using mechanical pencil tips.

Authors:  Abdelhadi M Shebl; Khaled R Zalata; Maha M Amin; Amira K El-Hawary
Journal:  Diagn Pathol       Date:  2011-12-01       Impact factor: 2.644

5.  Tissue microarrays: applications in study of p16 and p53 alterations in Ewing's cell lines.

Authors:  Rosa Noguera; Isidro Machado; Marta Piqueras; Jose Antonio Lopez-Guerrero; Samuel Navarro; Empar Mayordomo; Antonio Pellin; Antonio Llombart-Bosch
Journal:  Diagn Pathol       Date:  2008-07-15       Impact factor: 2.644

6.  Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia.

Authors:  Maura Rossi; Fabio Fuligni; Maria Ciccone; Claudio Agostinelli; Simona Righi; Marco Luciani; Maria Antonella Laginestra; Gian Matteo Rigolin; Maria Rosaria Sapienza; Anna Gazzola; Claudia Mannu; Antonio Cuneo; Stefano Pileri; Pier Paolo Piccaluga
Journal:  Biomed Res Int       Date:  2013-12-12       Impact factor: 3.411

7.  HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.

Authors:  Jessica N McAlpine; Kimberly C Wiegand; Russell Vang; Bridgett M Ronnett; Anna Adamiak; Martin Köbel; Steve E Kalloger; Kenneth D Swenerton; David G Huntsman; C Blake Gilks; Dianne M Miller
Journal:  BMC Cancer       Date:  2009-12-10       Impact factor: 4.430

8.  Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.

Authors:  Faisal M Fadlelmola; Minglong Zhou; Ronald J de Leeuw; Nirpjit S Dosanjh; Karynn Harmer; David Huntsman; Wan L Lam; Diponkar Banerjee
Journal:  Mol Cancer       Date:  2008-01-07       Impact factor: 27.401

9.  Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.

Authors:  Liesel M FitzGerald; Ilir Agalliu; Karynn Johnson; Melinda A Miller; Erika M Kwon; Antonio Hurtado-Coll; Ladan Fazli; Ashish B Rajput; Martin E Gleave; Michael E Cox; Elaine A Ostrander; Janet L Stanford; David G Huntsman
Journal:  BMC Cancer       Date:  2008-08-11       Impact factor: 4.430

10.  Numerical and structural genomic aberrations are reliably detectable in tissue microarrays of formalin-fixed paraffin-embedded tumor samples by fluorescence in-situ hybridization.

Authors:  Heike Horn; Julia Bausinger; Annette M Staiger; Maximilian Sohn; Christopher Schmelter; Kim Gruber; Claudia Kalla; M Michaela Ott; Andreas Rosenwald; German Ott
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.